DK392384A - Inklusionsforbindelse af n,n-dimethyl-2-chlor-5-(3-methyl-2-(phenylimino)-4-thiazolin-4-yl)-phenylsulfonamid og beta-cyclodextrin, dens fremstilling og anvendelse som laegemiddel - Google Patents

Inklusionsforbindelse af n,n-dimethyl-2-chlor-5-(3-methyl-2-(phenylimino)-4-thiazolin-4-yl)-phenylsulfonamid og beta-cyclodextrin, dens fremstilling og anvendelse som laegemiddel Download PDF

Info

Publication number
DK392384A
DK392384A DK392384A DK392384A DK392384A DK 392384 A DK392384 A DK 392384A DK 392384 A DK392384 A DK 392384A DK 392384 A DK392384 A DK 392384A DK 392384 A DK392384 A DK 392384A
Authority
DK
Denmark
Prior art keywords
thiazolin
phenylimino
chlor
cyclodextrin
beta
Prior art date
Application number
DK392384A
Other languages
Danish (da)
English (en)
Other versions
DK392384D0 (da
Inventor
Heinz-Ruediger Seidel
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK392384D0 publication Critical patent/DK392384D0/da
Publication of DK392384A publication Critical patent/DK392384A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nanotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Materials Engineering (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
DK392384A 1983-08-16 1984-08-15 Inklusionsforbindelse af n,n-dimethyl-2-chlor-5-(3-methyl-2-(phenylimino)-4-thiazolin-4-yl)-phenylsulfonamid og beta-cyclodextrin, dens fremstilling og anvendelse som laegemiddel DK392384A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833329517 DE3329517A1 (de) 1983-08-16 1983-08-16 Einschlussverbindung von n,n-dimethyl-2-chlor-5-(3-methyl-2-(phenylimino)-4-thiazolin-4-yl)phenylsulfonamid, verfahren zu ihrer herstellung sowie pharmazeutische praeparate

Publications (2)

Publication Number Publication Date
DK392384D0 DK392384D0 (da) 1984-08-15
DK392384A true DK392384A (da) 1985-02-17

Family

ID=6206641

Family Applications (1)

Application Number Title Priority Date Filing Date
DK392384A DK392384A (da) 1983-08-16 1984-08-15 Inklusionsforbindelse af n,n-dimethyl-2-chlor-5-(3-methyl-2-(phenylimino)-4-thiazolin-4-yl)-phenylsulfonamid og beta-cyclodextrin, dens fremstilling og anvendelse som laegemiddel

Country Status (10)

Country Link
EP (1) EP0141076A1 (ko)
JP (1) JPS6058969A (ko)
KR (1) KR850001737A (ko)
AU (1) AU3196184A (ko)
DE (1) DE3329517A1 (ko)
DK (1) DK392384A (ko)
ES (1) ES535135A0 (ko)
GR (1) GR80116B (ko)
PT (1) PT79080B (ko)
ZA (1) ZA846327B (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6081166A (ja) * 1983-10-11 1985-05-09 Fujisawa Pharmaceut Co Ltd ２−ニトロオキシメチル−６−クロロピリジンのβ−シクロデキストリン包接化合物およびその製造法
JPH08777B2 (ja) * 1985-04-08 1996-01-10 武田薬品工業株式会社 経口用抗菌固型組成物
YU45837B (sh) * 1988-01-18 1992-07-20 LEK TOVARNA FARMACEVTSKIH IN KEMIČKIH IZDELKOV d.d. Postopek za pripravo novega inkluzijskega kompleksa nikardipina oz. njegovega hidroklorida z beta-ciklodekstrinom
KR100503200B1 (ko) * 2000-09-05 2005-07-25 주식회사 포스코 석탄 건조설비의 석탄 불출량 제어장치

Also Published As

Publication number Publication date
DK392384D0 (da) 1984-08-15
PT79080B (de) 1986-09-08
DE3329517A1 (de) 1985-02-28
GR80116B (en) 1984-12-14
ES8601694A1 (es) 1985-11-16
AU3196184A (en) 1985-02-21
JPS6058969A (ja) 1985-04-05
PT79080A (de) 1984-09-01
EP0141076A1 (de) 1985-05-15
ZA846327B (en) 1985-03-27
KR850001737A (ko) 1985-04-01
ES535135A0 (es) 1985-11-16

Similar Documents

Publication Publication Date Title
FI840820A (fi) Sanitetsbinda som behaoller sin elastiska form.
DK143584A (da) Crotonesterholdige copolymerisater, deres fremstilling og anvendelse som fortykkelses- og slettemiddel
FI880423A (fi) Folier som kan tillslutas.
FI851636A0 (fi) Behaollare som kan saettas under tryck.
FI831670A0 (fi) Pressvals foer pappersmaskin, som aer foersedd med en elastisk ytbelaeggning av skiktkonstruktion spress foer pappersmaskin daer det anvaends en ifraogavarande pressvals
FI844367A0 (fi) Enhetligt centralcellelement avsett foer en cellkonstruktion som anvaends vid filterpresselektrolys.
FI841346A (fi) Tio2 med fluoridjoner innehaollande oeverdrag.
FI881929A0 (fi) Foerfarande foer framstaellning av foereningar vilka aer anvaendbara som mellanprodukter vid framstaellning av vinylcefalosporinderivat.
ES537651A0 (es) Un procedimiento para la preparacion de una composicion copolymerica de etileno-acrilato plastica pirorretartante y oleorresistente.
FI845146L (fi) Effektkaella, som aer utrustad med omvaent traodad sekundaerspole och pullsbreddmodulerad spaoningsmatning.
FI843800A0 (fi) Byggnadselement och takkonstruktion som omfattar flera saodana element.
FI850250L (fi) Trimmningsfaotolj med armstoed som motionsapparat.
FI844195A0 (fi) Ketonfoerening som inhiberar effekten av en metallkatalysator tillhoerande platinagruppen och organopolysiloxankompositioner innehaollande den.
FI843924L (fi) Zirkoniumoxid-titanoxid- kiseloxidtergeler och deras anvaendning som katalysatorbaerare.
FI880424A (fi) Folier som kan tillslutas.
DK392384A (da) Inklusionsforbindelse af n,n-dimethyl-2-chlor-5-(3-methyl-2-(phenylimino)-4-thiazolin-4-yl)-phenylsulfonamid og beta-cyclodextrin, dens fremstilling og anvendelse som laegemiddel
FI830968L (fi) Foerfarande foer beaktande av straolningsbakgrunden foer bestaemning av straolningsintensiteter som uppstaor i kroppar som skall analyseras.
FI851167A0 (fi) /(pyridinyl)-2-pyrimidinyl/karbamider anvaendbara som hjaertlaekemedel och deras framstaellningsfoerfarande.
FI840822A0 (fi) Azolylmetylcykloalkaner, foerfarande foer deras framstaellning och deras anvaendning som laekemedel
FI841914A0 (fi) Varningssystem foer flygplan, som landar med landningsstaellet uppfaellt.
FI840588A0 (fi) N-sulfenylerade hydantoiner, foerfarande foer deras framstaellning och deras anvaendning som mikrobizider
FI842702A0 (fi) Foerfarande foer separation av arsenik fraon syraloesningar som innehaoller den.
DK537587A (da) Halogencyklopropylforbindelser, deres fremstilling og anvendelse som herbicidt middel
FI842197A (fi) Anvaendningsfoerfarande och anordning som utestaenger en samkaella.
DK54284D0 (da) Substituerede oximethre,deres fremstilling og anvendelse som skadedyrsbekaempelsesmiddel

Legal Events

Date Code Title Description
ATS Application withdrawn